Trial Profile
Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Dihydroartemisinin/piperaquine
- Indications Falciparum malaria
- Focus Therapeutic Use
- Acronyms MIM
- 08 Feb 2021 Status changed from recruiting to completed.
- 27 Feb 2017 Planned End Date changed from 1 Feb 2017 to 1 Feb 2018.
- 27 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.